Assay and method for the assessment of responders and non-responders to NK cell modulation by immunoglobulin therapy

Details for Australian Patent Application No. 2009203688 (hide)

Owner Octapharma AG

Inventors Meuer, Stefan; Giese, Thomas; Haag, Stefan; Romisch, Jurgen; Jacobi, Christian

Agent Davies Collison Cave

Pub. Number AU-A-2009203688

PCT Pub. Number WO2009/087219

Priority 08100251.1 09.01.08 EP

Filing date 9 January 2009

Wipo publication date 16 July 2009

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/087219 Priority application(s): WO2009/087219

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009203693-Pyrimidines as kinase inhibitors

2009203682-Osteogenic differentiation of bone marrow stem cells and mesenchymal stem cells using a combination of growth factors